HomeComparePYCFF vs ARCC

PYCFF vs ARCC: Dividend Comparison 2026

PYCFF yields 3.84% · ARCC yields 10.82%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PYCFF wins by $1450.80M in total portfolio value
10 years
PYCFF
PYCFF
● Live price
3.84%
Share price
$1.49
Annual div
$0.06
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1450.82M
Annual income
$1,381,649,961.35
Full PYCFF calculator →
ARCC
Ares Capital Corporation
● Live price
10.82%
Share price
$17.74
Annual div
$1.92
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$1.16
Full ARCC calculator →

Portfolio growth — PYCFF vs ARCC

📍 PYCFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPYCFFARCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PYCFF + ARCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PYCFF pays
ARCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PYCFF
Annual income on $10K today (after 15% tax)
$326.17/yr
After 10yr DRIP, annual income (after tax)
$1,174,402,467.15/yr
ARCC
Annual income on $10K today (after 15% tax)
$919.95/yr
After 10yr DRIP, annual income (after tax)
$0.99/yr
At 15% tax rate, PYCFF beats the other by $1,174,402,466.16/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PYCFF + ARCC for your $10,000?

PYCFF: 50%ARCC: 50%
100% ARCC50/50100% PYCFF
Portfolio after 10yr
$725.42M
Annual income
$690,824,981.25/yr
Blended yield
95.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARCC right now

PYCFF
No analyst data
Altman Z
-0.4
Piotroski
3/9
ARCC
Analyst Ratings
24
Buy
7
Hold
Consensus: Buy
Price Target
$21.88
+23.3% upside vs current
Range: $21.00 — $23.00
Altman Z
0.8
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PYCFF buys
0
ARCC buys
0
No recent congressional trades found for PYCFF or ARCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPYCFFARCC
Forward yield3.84%10.82%
Annual dividend / share$0.06$1.92
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%-50%
Portfolio after 10y$1450.82M$24.5K
Annual income after 10y$1,381,649,961.35$1.16
Total dividends collected$1445.85M$1.1K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: PYCFF vs ARCC ($10,000, DRIP)

YearPYCFF PortfolioPYCFF Income/yrARCC PortfolioARCC Income/yrGap
1← crossover$11,467$767.45$11,381$541.15+$86.00PYCFF
2$13,915$1,644.99$12,621$284.08+$1.3KPYCFF
3$18,620$3,731.05$13,827$145.31+$4.8KPYCFF
4$29,256$9,332.01$15,062$73.43+$14.2KPYCFF
5$58,710$27,406.00$16,364$36.89+$42.3KPYCFF
6$165,619$102,799.37$17,757$18.49+$147.9KPYCFF
7$719,259$542,046.80$19,258$9.25+$700.0KPYCFF
8$5,169,670$4,400,063.55$20,880$4.63+$5.15MPYCFF
9$64,644,531$59,112,983.40$22,636$2.32+$64.62MPYCFF
10$1,450,819,609$1,381,649,961.35$24,539$1.16+$1450.80MPYCFF

PYCFF vs ARCC: Complete Analysis 2026

PYCFFStock

Mount Logan Capital Inc.is an investment firm primarily focused on investing in public and private debt securities. The Company holds and actively manages and monitors a seed portfolio of loans and other investments with credit-oriented characteristics. The company was formerly known as Marret Resource Corp. and changed its name to Mount Logan Capital Inc. in October 2018. Mount Logan Capital Inc. is based in Toronto, Canada with an additional office in New York City.

Full PYCFF Calculator →

ARCCBDC

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.

Full ARCC Calculator →
📬

Get this PYCFF vs ARCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PYCFF vs SCHDPYCFF vs JEPIPYCFF vs OPYCFF vs KOPYCFF vs MAINPYCFF vs HTGCPYCFF vs GBDCPYCFF vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.